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Chronic HBV infection, which is accompanied by a
weak and oligoclonal T cell response, is the most com-
mon cause of hepatocellular carcinoma (HCC). Current
antiviral therapies do not eliminate the virus, but T cell
therapy will very likely do so. From PBMCs of two
HLA-A2+ acutely infected patients and a donor who
cleared HBV infection we have established several HBV-
specific monoclonal T cell lines. Thereof we isolated 11
different T cell receptors (TCR) that are specific for the
HBV S-protein derived peptides S20 (FLLTRILTI) and
S172 (WLSLLVPFV) or for the C18 core-peptide
(FLPSDFFPSV). The aim of this study was a functional
comparison of our set of HBV-specific TCRs in order to
identify TCRs with optimal recognition of HBV peptides
presented on HLA-A2.
By murinization and codon-optimisation of gene
sequences of TCR a and b chains, fused by a P2A ele-
ment for polycystronic expression, TCR expression after
retroviral transduction was increased 2-fold to 60% of
PBMCs expressing an HBV-specific TCR.
PBMCs transduced with the 11 optimised HBV-specific
TCRs were compared in killing assays using peptide-
pulsed T2 cells, LCLs and HBV-replicating HepG2.2.15
cells as targets. CD8+ T cells transduced with the core-
specific TCRs killed target cells loaded with 0.01 nM of
peptide. Cells specific for the S20 and S172 peptide were
less sensitive with a specific lysis as low as 0.1 nM. Expres-
sion of most of the HLA-A2 restricted HBV-specific TCRs
in CD4+ T cells also led to specific cytotoxicity, which was
10-fold reduced in sensitivity compared to CD8+ T cells
and independent of CD8 co-receptor binding. Notably,
our HBV-specific TCRs recognised peptide presented on
various different HLA-A2 subtypes.
CD8+ T cells transduced with HBV-specific TCRs
were also able to recognise endogenously processed pep-
tides and specifically kill HBV-replicating hepatoma cells
and strongly reduce cccDNA levels in HBV-infected
HepaRG cells.
In addition, intracellular cytokine staining after stimu-
lation showed that the TCR-transduced CD8+ T cells
were polyfunctional, secreting INF-g, TNF-a and IL-2,
whereas CD4+ T cells produced mainly TNF-a and/or
IL-2.
We will further analyse our HBV-specific TCRs in
HBV/HLA-A2 transgenic mice in order to identify the
TCR that confers best antiviral activity. Our HBV-speci-
fic TCRs may be used for elucidating specific anti-HBV
mechanisms exerted by T cells, and most importantly,
for adoptive T cell therapy of chronic hepatitis B and
HBV-induced HCC.
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